What Is Sculptra (PLLA)? Uses, Who It Suits, Risks and FDA Status

What is Sculptra, and what is PLLA

Sculptra is an injectable made of PLLA (poly-L-lactic acid) particles, and the US FDA classes it as an injectable dermal filler [1][2]. It is not a cream and not a collagen supplement.

According to the FDA label, Sculptra contains PLLA particles, sodium carboxymethylcellulose and mannitol [2]. The doctor mixes the powder with sterile water for injection before use, and may add lidocaine just before injecting [1][2].

PLLA is a polymer that the body can break down [5]. A review explains that the particles cause a controlled inflammatory reaction to a foreign material, which activates fibroblasts to make the body's own collagen [5]. That is why it is called a collagen stimulator. For the whole group, see [[collagen-stimulator-types-explained]].

What is Sculptra used for, according to the label and studies

The US FDA label lists 3 indications: nasolabial folds and other facial wrinkles, fine lines and wrinkles in the cheeks, and facial fat loss in people with HIV [2]. The first two apply only to people with a normal immune system [2].

The first indication was facial fat loss in people with HIV, approved on 3 August 2004. On 28 July 2009 the FDA widened it to nasolabial folds and other facial wrinkles [4], and in April 2023 it added fine lines and wrinkles in the cheeks [1].

For the cheek indication, the FDA summarised a randomised, evaluator-blinded trial that compared Sculptra with no treatment in 149 people. The trial was run by the maker to support approval [3]. A blinded evaluator scored cheek wrinkles on the maker's scale at month 12. A responder was someone who improved by at least one grade in both cheeks. The responder rate was 70.7% with Sculptra and 25.9% with no treatment [3].

Most participants were women (96.6%), White (90.6%), with an average age of 60.7, and only 2 were Asian [3]. This document cannot tell you whether the numbers would be the same for Asian skin.

A 2024 systematic review pooled 11 randomised trials. Some found thicker dermis, and some reported effects lasting at least 25 months, but 5 of the 11 trials had a high risk of bias. The authors judged the evidence for facial rejuvenation to be low quality and said it needs confirming [5].

How long does Sculptra last, and when do you see results

There is no standard figure: the FDA page says results may last up to 24 months, but the label says how fast the material breaks down in people is not known [1][2].

The label says the treated fold or wrinkle is expected to improve gradually over several weeks after injection, because the effect builds up slowly. It therefore warns against overfilling [2]. So the time to a visible result differs from person to person, and the sources used here give no standard number.

In the systematic review, some trials reported that improvement was still present at 25 months or more [5]. The label adds that safety and effectiveness beyond 3 years from the first injection, in people with a normal immune system, have not been studied in clinical trials [2].

Who is Sculptra for, and who should not have it

The label limits use to people with a normal immune system and bars it for anyone allergic to a component, with a history of severe allergy, or prone to keloid scars [2]. In the cheek trial, participants had moderate or severe cheek wrinkles [3].

The label also says safety and effectiveness have not been evaluated in people who are pregnant, breastfeeding or under 18, or in people with connective tissue disease, bleeding disorders or immunosuppressive treatment [2]. People taking blood thinners or drugs that affect platelets may bruise or bleed more at the injection site [2].

It adds that use in the lips has not been evaluated, and injection around the eyes has not been studied, with published reports of more lumps in that area [2].

The label's contraindications are these [2].

• Allergy to any component of Sculptra
• History of anaphylaxis, or several severe allergies
• Known history of, or tendency to, keloid or raised scars
• Allergy to lidocaine or related anaesthetics, when Sculptra is mixed with lidocaine

What are the side effects and risks of Sculptra

Swelling, tenderness, redness and bruising are common, lumps can appear days to months later, and blocked blood vessels are rare but serious [2].

The table comes from a 14-day diary kept by the 116 people who received Sculptra Aesthetic in a nasolabial-fold trial that compared it with another product. It counts every level of severity together [2]. The label's duration table shows that of the 94 people who reported swelling, 87 said it lasted 7 days or less [2].

Nodules and papules under the skin are the risk the label stresses. Over the 13-month trial, doctors recorded nodules in 8.6% and papules in 8.6% of people who received Sculptra Aesthetic [2]. The label says these are usually palpable but painless, appear days to months after injection and can take a long time to clear [2]. Interim results of a post-approval study reported a higher risk of lumps in people with more severe wrinkles before injection, particularly around the marionette lines [2].

The label warns that if the product enters a blood vessel it can cause blockage, local skin death, vision problems, blindness or stroke, which are rare but serious [2]. A change in vision, blanching of the skin, unusual pain during or soon after the procedure, or signs of a stroke need medical attention at once [2].

Other cautions on the label: avoid sun, UV light and extreme temperatures until early swelling and redness have settled [2]. A laser or peel after treatment may cause an inflammatory reaction at the implant site [2]. The particles may show up on CT, MRI and ultrasound, so tell any radiologist [2]. The label expects the user to be a trained health professional who knows the anatomy and the product [2].

Is Sculptra FDA approved, and what about Thailand

The US FDA approved Sculptra through the PMA route from 2004, for the labelled indications only; the status in Thailand has to be checked with the Thai FDA (อย.) [2][4][6]. PMA (premarket approval) is the FDA's pre-market approval route for medical devices [4].

Approval covers the stated indications only. The label says safety and effectiveness have not been evaluated at other sites, or in larger amounts or at other frequencies than specified [2]. The FDA documents name the applicant as Q-Med AB, a Galderma affiliate [3].

In Thailand, the Thai FDA said in 2023 that fillers are medical devices that makers, importers and sellers must have licensed before selling, and it advises people to check the registration number on the Thai FDA website or by QR code [6]. The FDA documents call Sculptra a dermal filler [1]. This article could not confirm the Thai registration of each Sculptra product, so ask the clinic for the registration number and check it with the Thai FDA before treatment.

What should you ask a doctor before Sculptra

Ask about the product actually used, its registration number, the labelled indications, the risk of lumps and blocked vessels, and the plan if something goes wrong [2][6]. Sculptra is a procedure for a licensed doctor, not something to buy and inject yourself.

If you wonder how it differs from skin boosters and hyaluronic acid fillers, read [[skin-booster-vs-filler]], and for a similar material see [[juvelook-pdlla-explained]].

Questions to prepare [2][3][6].

• Is the product really Sculptra, and does the registration number on the box match the Thai FDA website? [6]
• Is the area I want treated one of the labelled indications? [2]
• I have a history of severe allergy or keloid, or I take immunosuppressants or blood thinners: what must I tell you? [2]
• If a lump or another problem appears, who looks after it and how do I reach you? [2]
• Are you trained in this product, and do you hold a medical licence? [2]
• How many people with skin and ancestry like mine were in the studies you rely on? [3]